Omnicare's Asset Sale Agreement with GenieRx Holdings

Omnicare, LLC, a CVS Health subsidiary, recently announced its entry into an asset purchase agreement with GenieRx Holdings LLC. GenieRx, a collaboration between Milrose Capital LLC and Integro Asset Management LLC, will function as the "stalking horse bidder" in Omnicare's court-supervised sale process. David Azzolina, President of Omnicare, highlighted the company's clinical expertise and commitment to skilled nursing and senior living communities.

Omnicare prioritizes supporting skilled nursing and assisted living providers by focusing on compliance with regulatory standards and enhancing operational efficiency. Their strategies involve transparent pricing, clinical initiatives aligned with CMS value-based purchasing, and analytics supporting care models like ISNPs and ACOs. For assisted living communities, Omnicare emphasizes partnerships in pharmacy services and improvements to billing, delivery, and communication systems.

The agreement with GenieRx sets a benchmark for Omnicare’s asset sale, with competing bids required by April 30, 2026, and a possible auction on May 5, 2026. The restructuring process details, including the sale's approval hearing, will be made available following the auction. GenieRx's role as a stalking horse bidder allows for comprehensive evaluation of other bids, with Omnicare's restructuring efforts supported by legal counsel from Jenner & Block LLP and Haynes Boone, and investment advice from Houlihan Lokey and Alvarez & Marsal.

Omnicare is renowned for its extensive pharmacy services within the long-term care sector, focusing on the needs of the aging market through services to skilled nursing and senior living communities. For further information, visit Omnicare’s official website. CVS Health, Omnicare's parent company, remains a key player in health solutions, offering a wide network of retail pharmacies and a formidable presence in health insurance and pharmacy benefits management.